Le Conseil International des Excipients Pharmaceutiques - Europe

Tweet this page
<
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
>
Registration as it was on 07 Nov 2024
How to read and use this data card.
Download this datacard
The following entries are flagged as duplicates of this organisation: 28353785401-43

Overview

Lobbying Costs

10,000€

Financial year: Jan 2023 - Dec 2023

Lobbyists (Full time equivalent)

0.1 Fte (1)

Lobbyists with EP accreditation

0

High-level Commission meetings

0

Lobbying Costs over the years

  • Info

    Le Conseil International des Excipients Pharmaceutiques - Europe   (IPEC Europe)

    EU Transparency Register

    341962119314-36 First registered on 26 Oct 2015

    Goals / Remit

    1. To be the primary voice of European producers, suppliers and users of pharmaceutical excipients.

    2. To develop, implement and promote voluntary, harmonised guidance for the pharmaceutical industry which is designed to ensure that excipients used in finished drug products meet the appropriate standards for quality, safety and functionality.

    3. To assist, educate, and cooperate with other industry organizations and scientific bodies working to advance public health on matters relating to the manufacture, use and functionality of excipients.

    4. To provide real-time information on excipient legislation via, for example, the IPEC Europe website (https://www.ipec-europe.org) and the newsletter ‘Excipients Insight’.

    Main EU files targeted

    The Revision of the EU general pharmaceuticals legislation: https://health.ec.europa.eu/medicinal-products/pharmaceutical-strategy-europe/reform-eu-pharmaceutical-legislation_en

    Directive 2011/62/EU of 8 June 2011 amending Directive 2001/83/EC on the Community code relating to medicinal products for human use, as regards the prevention of the entry into the legal supply chain of falsified medicinal products

    European Commission Guidelines of 19 March 2015 on the formalised risk assessment for ascertaining the appropriate good manufacturing practice for excipients of medicinal products for human use (OJ 2015/C 95/02)

    Address

    Head Office
    Rue Marie de Bourgogne 52
    Brussels 1000
    BELGIUM
    EU Office
    Rue Marie de Bourgogne 52
    Brussels 1000
    BELGIUM

    Website

    https://www.ipec-europe.org/

  • People

    Total lobbyists declared

    1

    Employment timeLobbyists
    10%1

    Lobbyists (Full time equivalent)

    0.1

    Lobbyists with EP accreditation

    No lobbyists with EP accreditations

    Complementary Information

    None declared

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    Trade and business associations

  • Networking

    Affiliation

    IPEC Europe is member of IPEC Federation (ipec.org) and of EXCiPACT (excipact.org)

    Member organisations

    None declared

  • Financial Data

    Interests represented

    Promotes their own interests or the collective interests of their members

    Closed financial year

    Jan 2023 - Dec 2023

    Lobbying costs for closed financial year

    10,000€

    Major contributions in closed year

    None declared

    Intermediaries for closed year

    None declared

    Intermediaries for current year

    None declared

    Closed year Costs

    0€ - 10,000€

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)

    None declared

    Groups (European Parliament)

    N/A

    Communication activities

    IPEC Federation Position Statement on EU Guidelines on Risk Assessment for Excipients
    https://www.ipec-europe.org/guidelines.html

    IPEC Europe Task Force acts to help industry meet EU risk assessment guidelines for excipients
    https://www.ipec-europe.org/guidelines.html

    Other activities

    None declared

  • Meetings

    Meetings

    None declared

Download this datacard